Global Multiplex Biomarker Imaging Market Anticipated to Surge at a CAGR of 12% Through 2027

New research report offers a comprehensive analysis of the “Multiplex Biomarker Imaging Market: North America Expected to be the Most Attractive Regional Market During the Forecast Period: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027” The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market.

Request to view Sample Report @ https://www.mrrse.com/sample/3661

The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027).

Increased spending on cancer diagnostic and monitoring

Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising due to late diagnosis of cancer, especially with regard to blood and lung cancer, are resulting in need for more expensive treatments and medical procedures. The commercial success of multiplex biomarker imaging in research activities is driving demand for these systems in cancer research sector and is also expected to attract investment opportunities on clinical diagnostics applications in the near future. In order to curb the cancer wave, government in some countries are spending substantially on cancer diagnostic services and campaigns. According to National Health Society (NHS), U.K., cancer services incur a cost of around US$ 8.3 Bn to NHS, of which, majority of this amount is spent on diagnosis and monitoring. This shows the potential for multiplex biomarker imaging industry in cancer diagnostic and monitoring in future.

Increase in demand for multiplexing in multispectral imaging

Demand for multispectral imaging is increasing within multiplex biomarker imaging as it optimizes the opportunities for multiplexing while at the same time overcoming the effects of auto-fluorescence. These could serve multiple purposes such as detection of exact tumour location, expression of appropriate targetable surface markers, oxy-deoxy haemoglobin status, presence of necrosis or apoptosis and documentation of drug delivery. An increase in production base of multispectral imaging devices that could provide multiplexing is expected to fuel the revenue growth of device manufacturers.

Browse Full Report with TOC @ https://www.mrrse.com/multiplex-biomarker-imaging-market

Unclear regulatory guidance on the commercial sale of digital pathology imaging products

There is no clear regulatory guidance on commercial diagnostic use of whole slide imaging (WSI) products including multiplex biomarker imaging systems. As such regulatory bodies have indicated that there is no definitive period within which such guidelines could be formulated. In the U.S., multiplex biomarker imaging devices have found main usage in cancer research in translation laboratories and academic institutes. This hampers profit generation of the multiplex biomarker imaging system manufacturers as they are not able to target commercial clinical diagnostic laboratories.

Instruments largely used for research purpose only

Currently, multiplex biomarker imaging products are approved for research use only. Both across Europe and North America, multiplex biomarker imaging products are directly sold by companies; along with software and multiple year service agreements to laboratories, biopharmaceutical companies and academic institutes. This makes pricing restrictive as reimbursement rates in these regions have gone down largely. In absence of documented benefits, these systems are yet to be utilized fully.

Global Multiplex Biomarker Imaging Market Attractiveness Analysis by Region, 2017-2027

North America is estimated to dominate the global multiplex biomarker imaging market by region in terms of revenue in 2017, and the trend is projected to grow throughout the forecast period. North America market is the most attractive segment, with attractiveness index of 4.3 over the forecast period. Western Europe is expected to be second most attractive region in the global multiplex biomarker imaging market by region, with attractiveness index of 1.8 during the forecast period. MEA and Latin America are the least attractive segment for global multiplex biomarker imaging market, with attractiveness index of 0.1 over the forecast period.

Enquire about this Report @ https://www.mrrse.com/enquiry/3661

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us                                                                         

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Designed by CyFocus.com
Powered by CyFocus.net